NOTES: Transvaginal for Cancer Diagnostic Staging: Preliminary Clinical Application

September 2008
Surgical Innovation;Sep2008, Vol. 15 Issue 3, p161
Academic Journal
No abstract available.


Related Articles

  • NOTES transvaginal cholecystectomy: preliminary clinical application. Zorron, R.; Maggioni, L. C.; Pombo, L.; Oliveira, A. L.; Carvalho, G. L.; Filgueiras, M. // Surgical Endoscopy;Feb2008, Vol. 22 Issue 2, p542 

    Natural orifice translumenal endoscopic surgery (NOTES) is an emerging concept in the recent literature that could lead to potential benefits in clinical applications. Restricted to animal experiments, however, human procedures have not yet been published. Because of the technical and ethical...

  • Totally NOTES (T-NOTES) transvaginal cholecystectomy using two endoscopes: preliminary report. de Sousa, Luiz Henrique; de Sousa, José Américo Gomides; de Sousa Filho, Luiz Henrique; de Sousa, Murilo Miranda; de Sousa, Vitor Miranda; de Sousa, Ana Patricia Miranda; Zorron, Ricardo // Surgical Endoscopy;Nov2009, Vol. 23 Issue 11, p2550 

    Clinical applications of transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES) are still limited in the literature, mostly case reports performed by hybrid procedures with laparoscopic assistance. Avoiding complications from incisions is the main goal for natural orifice surgery....

  • Open-access transvaginal sonography in women of reproductive age with abnormal vaginal bleeding: a descriptive study in general practice. de Vries, Corlien J. H. // British Journal of General Practice;Jun2011, Vol. 61 Issue 587, p393 

    The article discusses a study which assessed the clinical value of open-access transvaginal sonography in women of reproductive age with abnormal vaginal bleeding in general practice. The study showed that open access transvaginal sonography contributed to the diagnostic and therapeutic...

  • Low-dose CT: new tool for screening lung cancer? Diederich, S.; Wormanns, D.; Heindel, W. // European Radiology;Oct2001, Vol. 11 Issue 10, p1916 

    Lung cancer is the leading cause of death from malignant tumours as it is very common and has a poor prognosis at advanced tumour stages. Prognosis could be improved by treatment at early stages. As these stages are usually asymptomatic, a diagnostic test that would allow detection of early...

  • Biomoda Files New Patent Application To Optimize CyPath Assay.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p427 

    The article reports on the move of cancer diagnostics company Biomoda Inc. to file an application for a U.S. patent that optimizes the use of CyPath diagnostic assay for lung cancer. It notes that the patent refines the use of fluorescent microscopy to increase the accuracy, sensitivity and...

  • Value Of The MRI In The Preoperative Staging Of Endometrial Cancer. Elhalwagy, Hosam; Auld, Barry J. // Internet Journal of Gynecology & Obstetrics;2007, Vol. 8 Issue 1, p3 

    Aims: This is a retrospective observational study aimed to assess accuracy of the MRI as a predictive tool for histopathological staging, correlation between MRI, transvaginal scan (TVS) and hysteroscopy, in relation to the histopathological (H/P) staging and the compliance to the NHS fast track...

  • Diagnosis of Lung Cancer by SHOX2 Gene Methylation Assay. Song, Lele; Yu, Haotian; Li, Yuemin // Molecular Diagnosis & Therapy;Jun2015, Vol. 19 Issue 3, p159 

    Lung cancer is the most prevalent cancer in the world. Few effective and cheap methods are available so far for early detection and screening of lung cancer. Although histological and cytological examinations are gold standards in lung cancer diagnosis, patients are always at late stages when...

  • Gamma Medica & Mayo Clinic Publish Preliminary Results of Low Dose Molecular Breast Imaging Screening Study for Women with Dense Breasts.  // Biomedical Market Newsletter;5/28/2011, p499 

    The article discusses the preliminary results of the Dose Molecular Breast Imaging Screening Study for Women with Dense Breasts released by Gamma Medica Inc. and Mayo Clinic in Northridge, Los Angeles, California. It notes that the results reveal that MBI was able to diagnose women with cancer....

  • Targeting Agent Flags Cells for Surgeons.  // USA Today Magazine;Oct2015 Newsletter Edition, Vol. 144 Issue 2845, p12 

    The article discusses the ongoing development and testing of molecules that can find and bind onto cancer cells that can grow into metastatic tumors. It notes that researchers from Cellectar Biosciences are conducting early-stage clinical trials on molecules that can bind to more than 60 types...

  • Primary Uterine Cervical Cancer: Correlation of Preoperative Magnetic Resonance Imaging and Clinical Staging (FIGO) with Histopathology Findings. Kraljević, Zdenko; Viskovie, Klaudija; Ledinsky, Mario; Zadravec, Dijana; Grbavac, Ivan; Bilandžija, Marijana; Soljacic-Vraneš, Hrvojka; Kuna, Krunoslav; Klasnic, Ksenija; Krolo, Ivan // Collegium Antropologicum;Jun2013, Vol. 37 Issue 2, p561 

    The most commonly used staging system for cervical cancer is based on the International Federation of Gynaecology and Obstetrics (FIGO) staging system. Magnetic resonance imaging (MRI) has been accepted as the optimal tool for eval-uation of the main prognostic factors and selection of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics